Allen Institute for Artificial Intelligence logo

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 8 months ago

Possible Interaction: Epoprostenol and Arachidonate



Research Papers that Mention the Interaction

Inclusion of arachidonate in the diet augmented both prostacyclin and thromboxane production by 25 to 35%.
The Journal of nutrition  •  1996  |  View Paper
Prostacyclin production of human adult endothelial cell cultures was stimulated by aracidonate and thrombin by 17 to 20 and 2 to 3-fold respectively.
In Vitro Cellular & Developmental Biology  •  2007  |  View Paper
PGI2 production under successive treatments with AA or ionophore was reduced by only approximately 30% after each treatment.
The American journal of physiology  •  1994  |  View Paper
Infusion of PGI2 at a dose of 2 mg/kg/min during 72 hours into the patients caused the decreased platelet aggregability to ADP and arachidonate but not to collagen, and a decreased tendency to production of TXA2 in PRP aggregated by arachidonate.
Prostaglandins  •  1981  |  View Paper
When the medium was supplemented with 30 microM arachidonate (saturating concentration), prostacyclin release still significantly decreased after 30 min of hypoxia but returned to baseline levels by 30 min of reoxygenation.
The American journal of physiology  •  1995  |  View Paper
A23187 and arachidonate increased both endothelial and smooth muscle prostacyclin production (P < 0.01).
Endocrinology  •  1993  |  View Paper
Addition of arachidonate to food enhanced TXA2 and PGF2 alpha releases and decreased PGI2 and PGE2 releases, while inhibiting the food-induced increases in JBF and O2 uptake; mefenamate inhibited these arachidonate actions.
The American journal of physiology  •  1989  |  View Paper
Formation of PGI2 , as well as TXA2, as measured by radioimmunoassay (RIA) of their metabolites, was increased in atherosclerotic aortic segments relative to nonatherosclerotic segments (P less than or equal to 0.05) at 0, 5, 10, 15, and 30 min of incubation with arachidonate.
Proceedings of the National Academy of Sciences of the United States of America  •  1988  |  View Paper
The valve subendothelial cells also released 10-fold more prostacyclin in response to arachidonate than did skin fibroblasts or smooth muscle cells.
Journal of molecular and cellular cardiology  •  1987  |  View Paper
The aggregation of the platelets to arachidonate was inhibited by cyclooxygenase inhibitors and by prostacyclin.
Thrombosis research  •  1983  |  View Paper
Show More